Cargando…

A first census of skin cancer specialist nurses across UK secondary care trusts

BACKGROUND: Skin cancer specialist nurses (SCSNs) support patients and work alongside healthcare professionals throughout the care pathway. Skin cancer management is rapidly evolving, with increasing and more complex treatment options now available, so the need for patient support is growing. While...

Descripción completa

Detalles Bibliográficos
Autores principales: Rammanohar, Jashmitha, Kotecha, Deeya, Hodgetts, Jackie, Reeken, Saskia, Daniels, Susanna, Corrie, Pippa G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290789/
https://www.ncbi.nlm.nih.gov/pubmed/37355649
http://dx.doi.org/10.1186/s12912-023-01374-x
_version_ 1785062565447991296
author Rammanohar, Jashmitha
Kotecha, Deeya
Hodgetts, Jackie
Reeken, Saskia
Daniels, Susanna
Corrie, Pippa G
author_facet Rammanohar, Jashmitha
Kotecha, Deeya
Hodgetts, Jackie
Reeken, Saskia
Daniels, Susanna
Corrie, Pippa G
author_sort Rammanohar, Jashmitha
collection PubMed
description BACKGROUND: Skin cancer specialist nurses (SCSNs) support patients and work alongside healthcare professionals throughout the care pathway. Skin cancer management is rapidly evolving, with increasing and more complex treatment options now available, so the need for patient support is growing. While SCSNs are a major source of that support, the provision of SCSN resource across the UK has never previously been assessed. We therefore undertook a first SCSN census on 1st June 2021. METHODS: An electronic survey was disseminated to UK hospital trusts and registered skin cancer healthcare professionals. Responses were identifiable only by the respective trust name. RESULTS: 112 responses from 87 different secondary care trusts were received; 92% of trusts reporting having at least 1 established SCSN post. Average SCSN staffing per trust was 2.4 (range 0–7) whole time equivalents, managing an average caseload of 83 (range 6–400) patients per week. SCSN workload had increased in 82% hospitals in the previous year and 30% of trusts reported being under-resourced. Most SCSN time was spent managing melanoma (as opposed to non-melanoma skin cancer) patients linked to surgical services. Regional variations existed, particularly associated with provision of lymphoedema services, nurse prescribing skills and patient access to clinical trials. The COVID-19 pandemic was associated with a marked increase in SCSN-led telemedicine clinics, but loss of training and education opportunities. CONCLUSIONS: SCSNs based in secondary care hospitals play a major role supporting both clinicians and patients throughout the care pathway. This first UK census confirmed that SCSN workload is increasing and in one third of hospital trusts, the work was reported to outstrip the staffing available to manage the volume of work. Regional variations in SCSN resource, workload and job role, as well as availability of certain skin cancer services were identified, providing valuable information to healthcare commissioners concerned with service improvement. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12912-023-01374-x.
format Online
Article
Text
id pubmed-10290789
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-102907892023-06-26 A first census of skin cancer specialist nurses across UK secondary care trusts Rammanohar, Jashmitha Kotecha, Deeya Hodgetts, Jackie Reeken, Saskia Daniels, Susanna Corrie, Pippa G BMC Nurs Research BACKGROUND: Skin cancer specialist nurses (SCSNs) support patients and work alongside healthcare professionals throughout the care pathway. Skin cancer management is rapidly evolving, with increasing and more complex treatment options now available, so the need for patient support is growing. While SCSNs are a major source of that support, the provision of SCSN resource across the UK has never previously been assessed. We therefore undertook a first SCSN census on 1st June 2021. METHODS: An electronic survey was disseminated to UK hospital trusts and registered skin cancer healthcare professionals. Responses were identifiable only by the respective trust name. RESULTS: 112 responses from 87 different secondary care trusts were received; 92% of trusts reporting having at least 1 established SCSN post. Average SCSN staffing per trust was 2.4 (range 0–7) whole time equivalents, managing an average caseload of 83 (range 6–400) patients per week. SCSN workload had increased in 82% hospitals in the previous year and 30% of trusts reported being under-resourced. Most SCSN time was spent managing melanoma (as opposed to non-melanoma skin cancer) patients linked to surgical services. Regional variations existed, particularly associated with provision of lymphoedema services, nurse prescribing skills and patient access to clinical trials. The COVID-19 pandemic was associated with a marked increase in SCSN-led telemedicine clinics, but loss of training and education opportunities. CONCLUSIONS: SCSNs based in secondary care hospitals play a major role supporting both clinicians and patients throughout the care pathway. This first UK census confirmed that SCSN workload is increasing and in one third of hospital trusts, the work was reported to outstrip the staffing available to manage the volume of work. Regional variations in SCSN resource, workload and job role, as well as availability of certain skin cancer services were identified, providing valuable information to healthcare commissioners concerned with service improvement. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12912-023-01374-x. BioMed Central 2023-06-25 /pmc/articles/PMC10290789/ /pubmed/37355649 http://dx.doi.org/10.1186/s12912-023-01374-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Rammanohar, Jashmitha
Kotecha, Deeya
Hodgetts, Jackie
Reeken, Saskia
Daniels, Susanna
Corrie, Pippa G
A first census of skin cancer specialist nurses across UK secondary care trusts
title A first census of skin cancer specialist nurses across UK secondary care trusts
title_full A first census of skin cancer specialist nurses across UK secondary care trusts
title_fullStr A first census of skin cancer specialist nurses across UK secondary care trusts
title_full_unstemmed A first census of skin cancer specialist nurses across UK secondary care trusts
title_short A first census of skin cancer specialist nurses across UK secondary care trusts
title_sort first census of skin cancer specialist nurses across uk secondary care trusts
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290789/
https://www.ncbi.nlm.nih.gov/pubmed/37355649
http://dx.doi.org/10.1186/s12912-023-01374-x
work_keys_str_mv AT rammanoharjashmitha afirstcensusofskincancerspecialistnursesacrossuksecondarycaretrusts
AT kotechadeeya afirstcensusofskincancerspecialistnursesacrossuksecondarycaretrusts
AT hodgettsjackie afirstcensusofskincancerspecialistnursesacrossuksecondarycaretrusts
AT reekensaskia afirstcensusofskincancerspecialistnursesacrossuksecondarycaretrusts
AT danielssusanna afirstcensusofskincancerspecialistnursesacrossuksecondarycaretrusts
AT corriepippag afirstcensusofskincancerspecialistnursesacrossuksecondarycaretrusts
AT rammanoharjashmitha firstcensusofskincancerspecialistnursesacrossuksecondarycaretrusts
AT kotechadeeya firstcensusofskincancerspecialistnursesacrossuksecondarycaretrusts
AT hodgettsjackie firstcensusofskincancerspecialistnursesacrossuksecondarycaretrusts
AT reekensaskia firstcensusofskincancerspecialistnursesacrossuksecondarycaretrusts
AT danielssusanna firstcensusofskincancerspecialistnursesacrossuksecondarycaretrusts
AT corriepippag firstcensusofskincancerspecialistnursesacrossuksecondarycaretrusts